WallStSmart
BWAY

Brainsway Ltd

NASDAQ: BWAY · HEALTHCARE · MEDICAL DEVICES

$15.88
-1.37% today

Updated 2026-04-29

Market cap
$655.34M
P/E ratio
90.94
P/S ratio
12.55x
EPS (TTM)
$0.18
Dividend yield
52W range
$4 – $17
Volume
0.2M

Brainsway Ltd (BWAY) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-20.0%
Last 4 quarters
Revenue YoY growth
+28.2%
Most recent quarter
EPS YoY growth
+59.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+8.1%
2026-03-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-11$0.06+39.9%$12.71$13.74+8.1%
2025-11-11$0.04-20.0%$16.12$15.78-2.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.05$0.06+39.9%$14.64M+28.2%
2025-09-30$0.05$0.04-20.0%$13.51M+28.7%
2025-06-30$0.03$0.05+66.7%$12.63M+26.3%
2025-03-31$0.02$0.02-14.2%$11.54M+26.8%
2024-12-31$0.02$0.04+100.0%$11.41M+26.4%
2024-09-30$0.01$0.02+100.0%$10.50M+26.5%
2024-06-30$-0.01$0.04+500.0%$10.01M+27.8%
2024-03-31$-0.02$0.01+133.5%$9.10M
2023-12-31$-0.01$0.01+176.0%$9.03M
2023-09-30$-0.03$-0.02+33.3%$8.30M
2023-06-30$-0.09$-0.10-11.1%$7.83M
2023-03-31$-0.10$-0.14-40.0%
2022-12-31$-0.13$-0.24-84.6%

Frequently asked questions

Has Brainsway Ltd beaten earnings estimates?
Brainsway Ltd has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -20.0% over the last 1 quarters.
How does BWAY stock react to earnings?
BWAY stock has moved an average of +3.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Brainsway Ltd's revenue growth rate?
Brainsway Ltd reported year-over-year revenue growth of +28.2% in its most recent quarter, with EPS growing +59.5% year-over-year.